Senior insider sale
10X GENOMICS, INC. — senior position signals high conviction
$2.39M
40K shares
What this filing means
STUELPNAGEL JOHN R plans to sell 40K shares of 10X GENOMICS, INC. valued at approximately $2.39M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 9/3/2026ACC: 0001957799-26-000170
40K
Shares to sell
$2.39M
Approx. market value
20K
Acquired (3 months)
1
Planned
1 completed
Securities Acquired — Last 3 Months1
Granted as founders shares
N/A
8/21/2017
20KTotal acquired20K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
8/21/2017 | Granted as founders shares N/A | 20K | — |
| Total | 20K | ||
Planned & Completed Dispositions2
Completed
—Completed
Units to sell
20K
Market value
$1.16M
8/11/2026
Planned — Approximate Date
NasdaqPlanned
Units to sell
20K
Market value
$1.24M
9/3/2026
Total
Units
40K
Value
$2.39M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
8/11/2026 | 20K | $1.16M | — | Completed |
| Planned — Approximate Date | ||||
9/3/2026 | 20K | $1.24M | Nasdaq | Planned |
| Total | 40K | $2.39M | ||